Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study | Zendy

Ask Tybjærg Nordestgaard | Zendy; Morten B. Thomsen | Zendy; Børge G. Nordestgaard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study

Author(s) -

Ask Tybjærg Nordestgaard,

Morten B. Thomsen,

Børge G. Nordestgaard

Publication year - 2015

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/dyv083

Subject(s) - mendelian randomization , metabolic syndrome , medicine , body mass index , type 2 diabetes , obesity , endocrinology , diabetes mellitus , blood pressure , waist , population , physiology , biology , genotype , genetics , environmental health , genetic variants , gene

Coffee is one of the most widely consumed beverages. We tested the hypothesis that genetically high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research